Amantadine is an anti-viral drug which is also used in Parkinson’s disease. The drug has been shown to reduce viral load in the context of the influenza virus, and in the COVID-19 setting, it may be able to decrease the viral load in SARS-CoV-2 positive patients.
Tags: AGING, ALVEOLAR EPITHELIAL CELLS, AMANTADINE, APOPTOTIC PROCESS, B-LYMPHOCYTES, BLOOD CELLS, BLOOD PLATELETS, CELL LINE, COAGULATION, COGNITION, COVID-19, ENDOCYTOSIS, ENDOSOMES, ENDOTHELIAL CELLS, EPITHELIAL CELLS, ERYTHROCYTES, EXCRETION, FIBROBLASTS, HEK293 CELLS, INFLAMMATORY RESPONSE, INNATE IMMUNE RESPONSE, LYSOSOMES, MACROPHAGES, MEMBRANE FUSION, NEURONS, NEUTROPHILS, REVERSE TRANSCRIPTION, SARS-COV-2, STEM CELLS, T-LYMPHOCYTES, TROPISM, TUMOR, VERO CELLS, VIRAL RELEASE FROM HOST CELL